Ptc Therapeutics, Inc. · NASDAQ:PTCT

Boulding Mark Elliott sold 10,462 Ptc Therapeutics, Inc. shares (Form 4)

Traded Jun 17, 2026 · Filed Jun 22, 2026

On Jun 17, 2026, Boulding Mark Elliott (EXEC. VP AND CLO) sold 10,462 Ptc Therapeutics, Inc. shares at an average US$78.65 for US$823K under a trading plan, leaving 105,272 shares. Filed Jun 22, 2026 (Form 4).

Sold
10,462 shares
Price
US$78.65 average (US$78.50 to US$79.25)
Value
US$823K
Holding after
105,272 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EXEC. VP AND CLO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 17, 2026Common StockOption exercise8,510US$46.54113,722Direct
Jun 17, 2026Common StockSale6,600US$78.50107,122Direct
Jun 17, 2026Common StockSale1,850US$79.24105,272Direct
Jun 17, 2026Common StockOption exercise2,012US$46.54107,284Direct
Jun 17, 2026Common StockSale1,703US$78.50105,581Direct
Jun 17, 2026Common StockSale309US$79.25105,272Direct

Source

View original at SEC

Related